Research Topics
Species | Paul D BrownSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Prospective study of quality of life in adults with newly diagnosed high-grade gliomasPaul D Brown
Division of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
J Neurooncol 76:283-91. 2006..To assess baseline quality of life (QOL) and its prognostic importance for adults with newly diagnosed high-grade gliomas, we analyzed QOL and outcome data prospectively collected in three phase II high-grade glioma protocols...
Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?Paul Brown
Department of Oncology, Mayo Clinic Rochester, Rochester, MN 55905, USA
Am J Clin Oncol 29:52-8. 2006..In this project, we examined the impact that participation in a randomized controlled trial of a multidisciplinary intervention designed to impact overall QOL had on fatigue for advanced cancer patients actively receiving treatment...
Detrimental effects of tumor progression on cognitive function of patients with high-grade gliomaPaul D Brown
Mayo Clinic, Rochester, MN 55905, USA
J Clin Oncol 24:5427-33. 2006..To assess the cognitive performance of high-grade glioma patients, prospectively collected cognitive performance data were analyzed...
Irradiation of the inguinal lymph nodes in patients of differing body habitus: a comparison of techniques and resulting normal tissue complication probabilitiesPaul D Brown
Division of Radiation Oncology, Mayo Clinic, Rochester, MN, USA
Med Dosim 29:217-22. 2004..Technique 1 for ectomorphs and mesomorphs and techniques 2 and 6 for endomorphs were optimal techniques for providing relatively homogeneous dose distributions within the target area while minimizing the dose to the femoral heads...
Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are neededPaul D Brown
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 70:1305-9. 2008..Currently, two Phase III trials are underway, one in Europe and one in North America, that will determine the effect of adjuvant WBRT on patients' quality of life, neurocognitive function, and survival...
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade gliomaPaul D Brown
Division of Radiation Ocology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 59:117-25. 2004....
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of lifePaul D Brown
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Am J Clin Oncol 31:163-8. 2008..To examine whether a caregiver can provide reliable proxy quality of life (QOL) ratings of their adult significant other with a newly diagnosed high-grade glioma...
Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trialPaul D Brown
Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 58:1153-60. 2004..Supratentorial pilocytic astrocytomas in adults are uncommon. A prospective clinical trial was conducted to obtain clinical and outcome data in these patients...
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177Paul D Brown
Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
J Clin Oncol 26:5603-9. 2008..Erlotinib, a selective EGFR inhibitor, was combined with temozolomide (TMZ) and radiotherapy (RT) in a phase I/II trial...
The neurocognitive effects of radiation in adult low-grade glioma patientsPaul D Brown
Division of Radiation Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Neuro Oncol 5:161-7. 2003..The weight of evidence suggests only sporadic, limited neurocognitive damage from focal radiotherapy at the doses usually prescribed for low-grade gliomas...
Predictors of survival in contemporary practice after initial radiosurgery for brain metastasesAnna Likhacheva
Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Int J Radiat Oncol Biol Phys 85:656-61. 2013..The purpose of this study was to determine whether, following multivariate adjustment, the number and volume of BM held prognostic significance in a cohort of patients initially treated with SRS alone...
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastasesPaul W Sperduto
University of Minnesota Gamma Knife, Minneapolis Radiation Oncology, Minneapolis, MN, USA
Int J Radiat Oncol Biol Phys 82:2111-7. 2012..The diagnosis-specific Graded Prognostic Assessment (GPA) was published to clarify prognosis for patients with brain metastases. This study refines the existing Breast-GPA by analyzing a larger cohort and tumor subtype...
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802Edward G Shaw
Department of Radiation Oncology, Wake Forest University School of Medicine, 2000 W First St, Winston Salem, NC 27104, USA
J Clin Oncol 30:3065-70. 2012....
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51Thomas B Daniels
Department of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 81:218-24. 2011..We sought to independently validate this prognostic index with a separate prospectively collected data set (Intergroup 86-72-51)...
Oncodiagnosis panel: 2002. Primary glial neoplasm or less likely an intracranial abscessPaul D Brown
Department of Oncology, Mayo Clinic, 200 SW 1st St, Rochester, MN 55905, USA
Radiographics 23:1591-611. 2003
Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?Steven E Schild
Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA
Am J Clin Oncol 33:633-6. 2010..This study was performed to evaluate the addition of temozolomide (TMZ) to whole brain radiotherapy (WBRT) for brain metastases from melanoma...
Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinomaAshley W Jensen
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 77:1449-56. 2010..To update our institutional experience with neoadjuvant chemotherapy and minimized radiotherapy vs. radiation monotherapy for intracranial germinoma...
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survivalPaul D Brown
Division of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
Neurosurgery 57:495-504; discussion 495-504. 2005..001), and greater extent of resection (P < 0.001). CONCLUSION: Baseline QOL was predictive of QOL over time. Gross total resection was associated with longer survival and improved QOL over time for patients with high-grade gliomas...
Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examinationPaul D Brown
Mayo Clinic, Division of Radiation Oncology, Rochester, MN 55905, USA
J Clin Oncol 21:2519-24. 2003..Only a small percentage of patients had cognitive deterioration after radiotherapy. However, more discriminating neurocognitive assessment tools may identify cognitive decline not apparent with the use of the MMSE...
Improving the quality of life of geriatric cancer patients with a structured multidisciplinary intervention: a randomized controlled trialMaria I Lapid
Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, 200 First Street, SW, Rochester, MN 55905, USA
Palliat Support Care 5:107-14. 2007..To examine the potential impact of elderly age on response to participation in a structured, multidisciplinary quality-of-life (QOL) intervention for patients with advanced cancer undergoing radiation therapy...
Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177Sunil Krishnan
Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA
Int J Radiat Oncol Biol Phys 65:1192-9. 2006..To evaluate the toxicity and maximum tolerated dose (MTD) of erlotinib plus radiation therapy (RT) in patients with glioblastoma multiforme (GBM) in a multicenter phase I trial...
Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo ClinicDavid A Schomas
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Neuro Oncol 11:437-45. 2009..Postoperative RT was associated with improved OS and PFS and is recommended for patients after subtotal resection or biopsy...
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiformeJann N Sarkaria
Mayo Clinic Rochester, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 81:468-75. 2011..On the basis of promising preclinical data, the safety and tolerability of therapy with the mTOR inhibitor RAD001 in combination with radiation (RT) and temozolomide (TMZ) was evaluated in this Phase I study...
Treatment options for brain metastases from melanomaRobert R McWilliams
Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA
Expert Rev Anticancer Ther 5:809-20. 2005..Future directions include combined modality therapy, the incorporation of novel agents and careful consideration of the structure of clinical trials for this disease...
Central neurocytoma: management recommendations based on a 35-year experienceJames L Leenstra
Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 67:1145-54. 2007..METHODS AND MATErials: The data from 45 patients with central neurocytomas diagnosed between 1971 and 2003 were retrospectively evaluated. Various combinations of surgery, radiotherapy (RT), and chemotherapy had been used for treatment...
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphomaNadia N Laack
Department of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
Int J Radiat Oncol Biol Phys 81:476-82. 2011....
Gamma knife radiosurgery of radiation-induced intracranial tumors: local control, outcomes, and complicationsAshley W Jensen
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 62:32-7. 2005..Radiosurgery is a safe and effective treatment option for radiation-induced intracranial tumors, most of which are typical meningiomas...
Measuring spiritual quality of life in patients with cancerMary E Johnson
Department of Chaplain Services, Mayo Clinic, Rochester, MN 55905, USA
J Support Oncol 5:437-42. 2007....
A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanomaKenneth R Olivier
Department of Radiation Oncology, University of Florida Health Science Center, Gainesville, Florida 32610 0385, USA
Cancer 110:1791-5. 2007..quot; The Mayo Clinic experience was analyzed to determine the efficacy of palliative RT...
Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumors: a pilot studyDona E C Locke
Division of Psychology, Mayo Clinic, Scottsdale, AZ 85259, USA
J Support Oncol 6:383-91. 2008....
Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective studyNadia N Laack
Division of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 63:1175-83. 2005..Slight improvements in some cognitive areas are consistent with practice effects attributable to increased familiarity with test procedures and content...
Single-fraction radiosurgery of benign intracranial meningiomasBruce E Pollock
Department of Neurological Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Neurosurgery 71:604-12; discussion 613. 2012..Stereotactic radiosurgery (SRS) of benign intracranial meningiomas is an accepted management option for well-selected patients...
Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysisO Kenneth Macdonald
Department of Radiation Oncology, Mayo Clinic, 200 1st Street S W, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 75:950-8. 2009..We analyzed the dosimetric differences between PT and SBRT in treating primary peripheral early-stage non-small-cell lung cancer...
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiformeKarla V Ballman
Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Neuro Oncol 9:29-38. 2007..Finally, there was a strong association between progression-free survival status and overall survival. PFS6 seems to be a reasonable end point for phase II trials in patients with recurrent glioblastoma...
Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomasShota Tanaka
Department of Neurological Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
World Neurosurg 74:147-52. 2010..To evaluate the efficacy of stereotactic radiosurgery (SRS) for patients with prolactin (PRL)-secreting pituitary adenomas that were refractory to medical management...
Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experienceBruce E Pollock
Department of Neurological Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 70:1325-9. 2008..To evaluate the efficacy and complications of stereotactic radiosurgery for patients with nonfunctioning pituitary adenomas (NFA)...
Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic ExperienceMelva E Pinn
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 71:498-506. 2008..To determine the acute and chronic toxic effects of radiotherapy in patients with systemic lupus erythematosus (SLE)...
Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractionsMichael C Stauder
Department of Radiation Oncology, Mayo Clinic, Rochester, USA
Radiother Oncol 99:166-71. 2011..Identify the incidence of early pulmonary toxicity in a cohort of patients treated with lung stereotactic body radiation therapy (SBRT) on consecutive treatment days...
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patientsDona E C Locke
Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, Arizona 85259, USA
J Pain Symptom Manage 34:628-38. 2007..The data suggest that the single-item LASA scales are valid for assessing QOL of cancer patients and are an appropriate alternative when a shorter instrument is warranted...
Stereotactic radiosurgery for recurrent or unresectable pilocytic astrocytomaChristopher L Hallemeier
Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA
Int J Radiat Oncol Biol Phys 83:107-12. 2012..To report the outcomes in patients with recurrent or unresectable pilocytic astrocytoma (PA) treated with Gamma Knife stereotactic radiosurgery (SRS)...
Stereotactic body radiation therapy in spinal metastasesKamran A Ahmed
Mayo Medical School, College of Medicine, Mayo Clinic, Rochester, MN, USA
Int J Radiat Oncol Biol Phys 82:e803-9. 2012..Based on reports of safety and efficacy, stereotactic body radiotherapy (SBRT) for treatment of malignant spinal tumors was initiated at our institution. We report prospective results of this population at Mayo Clinic...
Oncodiagnosis panel: 2002. Patient's symptoms not related to the lesion seen in the MR imagesPaul D Brown
Department of Oncology, Mayo Clinic, 200 SW 1st St, Rochester, MN 55905, USA
Radiographics 23:1591-611. 2003
Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial diseaseBruce E Pollock
Department of Neurological Surgery, Mayo Clinic and Foundation, Rochester, MN 55905, USA
J Neurooncol 61:73-80. 2003....
Innovation in the management of brain metastasesRavi D Rao
Department of Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
Oncology (Williston Park) 21:473-81; discussion 482, 484, 489. 2007..Novel therapies to enhance radiation responsiveness are also under investigation. In the current review, we discuss recent developments in the management of patients with brain metastases...
Melanoma-induced brain metastasesRobert R McWilliams
Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Expert Rev Anticancer Ther 8:743-55. 2008..Future directions include combined-modality therapy, the incorporation of novel agents, and careful consideration of the structure of clinical trials for this disease...
A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tractRobert L Foote
Division of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
Cancer 103:559-68. 2005..3-100%). CONCLUSIONS: The results of this study suggest that concurrent intraarterial cisplatin chemotherapy at a dose of 150 mg/m(2) with concomitant boost accelerated radiation therapy is not feasible...
Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case reportThomas B Daniels
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
J Neurooncol 93:263-7. 2009..To describe a rare case of optic neuritis onset after Gamma Knife stereotactic radiosurgery...
Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risksJann N Sarkaria
Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA
Clin Cancer Res 16:5573-80. 2010..The mammalian target of rapamycin (mTOR) functions within the phosphoinositide 3-kinase/Akt signaling pathway as a critical modulator of cell survival...
Organ preservation for advanced laryngeal carcinomaRobert L Foote
Department of Radiation Oncology, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Head Neck 28:689-96. 2006..Inclusion of patients with mobile vocal cords on larynx preservation trials may lead to overstatement of larynx preservation (LPR) and survival (OS) rates...
Oncodiagnosis panel: 2002. Optic nerve glioma or optic nerve meningiomaPaul D Brown
Department of Oncology, Mayo Clinic, 200 SW 1st St, Rochester, MN 55905, USA
Radiographics 23:1591-611. 2003
Low-grade gliomas in older patients: long-term follow-up from Mayo ClinicDavid A Schomas
Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA
Cancer 115:3969-78. 2009..Low-grade gliomas (LGGs) are uncommon in older patients, and long-term clinical behavior and prognostic factors are not well defined in this group...
Radiosurgery as primary management for meningiomas extending into the internal auditory canalBruce E Pollock
Department of Neurological Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Stereotact Funct Neurosurg 82:98-103. 2004..Radiosurgery is an excellent alternative to surgical excision for meningiomas in this location, especially if a subtotal resection is likely or a hearing-sacrificing operation such as a translabyrinthine approach is contemplated...
Cognitive sequelae of brain radiation in adultsNadia N Laack
Division of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Semin Oncol 31:702-13. 2004..Further studies need to be undertaken to elucidate the degree and cause of cognitive decline in adult patients undergoing multimodality therapy for cranial tumors...
Radiosurgery for cranial base chordomas and chondrosarcomasSunil Krishnan
Division of Radiation Oncology, Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Neurosurgery 56:777-84; discussion 777-84. 2005..Radiosurgery as an adjunct to surgical resection provides in-field tumor control for some patients, but radiation-related complications are relatively high, especially when radiosurgery is combined with fractionated radiation therapy...
Repeat radiosurgery for idiopathic trigeminal neuralgiaBruce E Pollock
Department of Neurological Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 61:192-5. 2005..Although frequently performed, the efficacy and safety of repeat trigeminal neuralgia radiosurgery is not well described...
Choroid plexus papillomas: a single institutional experienceSunil Krishnan
Division of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Neurooncol 68:49-55. 2004..After initial STR, reoperations for recurrence are required only half the time. Therefore, there seems to be no role for radiation therapy after initial STR. For STRs at first relapse, local control outcome is poor...
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalitiesJan C Buckner
Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
J Clin Oncol 21:251-5. 2003....
Treatment of brain metastases from melanomaRobert R McWilliams
Division of Medical Oncology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 78:1529-36. 2003..Chemotherapy may be gaining a role with newer agents that penetrate the blood-brain barrier. Combined modality therapy appears to be the future direction of treatment of multiple metastases...
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendrogliomaRobert B Jenkins
Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer Res 66:9852-61. 2006..Like combined 1p/19q deletion, the 1;19 translocation is associated with superior OS and progression-free survival in low-grade glioma patients...
Willingness of cancer patients to help family members to quit smokingYolanda I Garces
Department of Radiation Oncology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
Psychooncology 20:724-9. 2011..As a first step in this line of research, we sought to explore interest in playing a supportive role for smoking cessation as well as correlates of such interest among cancer survivors...
Informed consent in advanced laryngeal cancerRobert L Foote
Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Head Neck 29:230-5. 2007..This study was designed to evaluate the relationship between the informed consent process and the treatment received by patients with advanced laryngeal cancer...
A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgeryScott L Stafford
Division of Radiation Oncology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 55:1177-81. 2003..To evaluate the risk of clinically significant radiation optic neuropathy (RON) for patients having stereotactic radiosurgery of benign tumors adjacent to the optic apparatus...
Oncodiagnosis panel: 2002. Metastatic NSCLCPaul D Brown
Department of Oncology, Mayo Clinic, 200 SW 1st St, Rochester, MN 55905, USA
Radiographics 23:1591-611. 2003
Quality of life of caregivers of patients with advanced-stage cancerMatthew M Clark
Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
Am J Hosp Palliat Care 23:185-91. 2006..Further investigation is warranted in this area, including interventions specifically designed and targeted to both reduce caregiver burden and to improve caregiver QOL...
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation responseJann N Sarkaria
Department of Radiation Oncology, Laboratory Medicine and Pathology, and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA
Clin Cancer Res 12:2264-71. 2006..The intent of the current study was to address this relationship using several EGFR-amplified glioblastoma xenografts in an orthotopic athymic mouse model...
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trialEdward G Shaw
Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
J Neurosurg 109:835-41. 2008..In 1998, the Radiation Therapy Oncology Group initiated a Phase II study of observation for adults < 40 years old with cerebral low-grade glioma who underwent a neurosurgeon-determined gross-total resection (GTR)...
Long-term results of irradiation for paragangliomaAaron J Krych
Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 65:1063-6. 2006..Few data exist regarding long-term tumor control and late effects after EBRT or SRS...
Stereotactic radiosurgery for brainstem metastases: Survival, tumor control, and patient outcomesAamir Hussain
Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 67:521-4. 2007..Patients with brainstem metastases have limited treatment options. In this study, we reviewed outcomes after stereotactic radiosurgery (SRS) in the management of patients with brainstem metastases...
Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomasBruce E Pollock
Departments of Neurological Surgery and Radiation Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Neurosurgery 62:1271-6; discussion 1276-8. 2008..Confounding variables include histology, radiation dose, use of pituitary-suppressive medications, and length of follow-up...
Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experienceRobert C Miller
Department of Radiation Oncology, Mayo Clinic, Rochester, MN55905, USA
Int J Radiat Oncol Biol Phys 66:1178-86. 2006..The aim of this study was a retrospective assessment of neurotoxicity in patients with multiple sclerosis (MS) receiving external beam radiotherapy (EBRT) to the brain...
A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignanciesPaul D Brown
Division of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 63:1361-7. 2005..CONCLUSIONS: For long-term survivors after neck dissection and irradiation, especially those who are symptomatic, ultrasonographic carotid artery screening should be considered...
Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomasJames L Leenstra
Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Neurosurgery 67:27-32; discussion 32-3. 2010..To analyze the factors associated with anterior pituitary deficits after pituitary adenoma stereotactic radiosurgery (SRS)...
Stereotactic radiosurgery for patients with "radioresistant" brain metastasesPaul D Brown
Division of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
Neurosurgery 51:656-65; discussion 665-7. 2002..Adjuvant WBRT improves local control and decreases DBF but does not affect overall survival. Further studies are needed to determine which patients should receive WBRT...
Prognosis and treatment of spinal cord astrocytomaKiernan J Minehan
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 73:727-33. 2009..To identify the prognostic factors for spinal cord astrocytoma and determine the effects of surgery and radiotherapy on outcome...
Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remissionBruce E Pollock
Department of Neurological Surgery, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Neurosurg 106:833-8. 2007..The authors reviewed outcomes after stereotactic radiosurgery for patients with acromegaly and analyzed factors associated with biochemical remission...
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBMKurt A Jaeckle
Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USA
J Neurooncol 99:73-80. 2010..This regimen was not significantly active and radiosensitization was not observed. Non-EIAC patients with UGT1A1*28 variant alleles appear particularly sensitive to toxicity from irinotecan...
Radiosurgery for arteriovenous malformations of the basal ganglia, thalamus, and brainstemBruce E Pollock
Department of Neurologic Surgery, Division of Radiation Oncology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
J Neurosurg 100:210-4. 2004..The goal of this paper was to study these outcomes...
Reversible, strokelike migraine attacks in patients with previous radiation therapyJ D Bartleson
Departments of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Neuro Oncol 5:121-7. 2003..Radiation-induced vascular changes could provoke the episodes, with or without an underlying migraine diathesis. Recognition of this syndrome can help avoid invasive testing...
Evaluation of gamma knife radiosurgery in the treatment of oligodendrogliomas and mixed oligodendroastrocytomasAtom Sarkar
Department of Neurologic Surgery and the Division of Radiation Oncology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
J Neurosurg 97:653-6. 2002..Further study is needed to determine which subpopulation of these patients will have the best chances of enhanced survival from this treatment...
Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancerStephanie A Shintani
Department of Otolaryngology Head and Neck Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Int J Radiat Oncol Biol Phys 70:322-9. 2008..To evaluate the utility of positron emission tomography (PET)/computed tomography (CT) early after surgical resection and before postoperative adjuvant radiation therapy...
Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: association with connective tissue disorder severityDouglas G Gold
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Radiother Oncol 87:127-31. 2008..Building on our prior experience, we postulated that disease severity, as measured by the number of organ systems involved, may predict chronic radiation toxicity risk...
Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumorsChristina A Meyers
Department of Neuro Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 24:1305-9. 2006..Including this aspect of patient evaluation in addition to survival and time to tumor progression will yield better risk-versus-benefit assessments as well as provide a basis for improving interventions...
A methodology to determine margins by EPID measurements of patient setup variation and motion as applied to immobilization devicesJoann I Prisciandaro
Division of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
Med Phys 31:2978-88. 2004..Finally, this methodology provides direct evidence of treatment variation and thus can demonstrate with confidence, the superiority of one technique over another...
Outcome in adult low-grade glioma: the impact of prognostic factors and treatmentDavid Schiff
Neuro Oncology Center, University of Virginia Health Sciences Center, Box 800432, Charlottesville, VA 22908 0432, USA
Neurology 69:1366-73. 2007..We review contemporary knowledge regarding prognostic factors, our current evidence-based understanding of the roles and timing of radiation and chemotherapy, and ongoing clinical trials that will further elucidate management of LGGs...
Central nervous system tumorsJan C Buckner
Division of Medical Oncology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 82:1271-86. 2007..This article provides an overview of current diagnostic and treatment approaches for patients with primary and metastatic brain tumors...
Is there a role for radiation therapy in the management of Hürthle cell carcinoma?Robert L Foote
Division of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 56:1067-72. 2003..To determine the role that radiation therapy may have in the management of resected, unresectable, and metastatic Hürthle cell carcinoma...
Low-grade gliomas: the debate continuesPaul D Brown
Department of Oncology, Mayo Clinic Rochester, MN 55905, USA
Curr Oncol Rep 8:71-7. 2006..In this article we review the pertinent LGG literature published over the past few years and its impact on the management of LGGs...
Resolution of diabetes insipidus following gamma knife surgery for a solitary metastasis to the pituitary stalk. Case reportMark P Piedra
Mayo Medical School, Division of Radiation Oncology and Endocrinology, Rochester, Minnesota 55905, USA
J Neurosurg 101:1053-6. 2004..Three months after GKS the patient was able to reduce the medication she required for the DI. There was no evidence of pituitary failure and no negative effect on her vision...
